logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-21. Gender ratio by primary drug - ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2005 for countries supplying data [see all tables in this series...]

Part (iii) Gender ratio (ratio of males to females) among new clients entering inpatient treatment

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsBase (known status)
Bulgaria(1)6.23.01.0188
Czech Republic(2)1.71.80.82.010.02.91.5742
Denmark(3)2.31.22.50.76.487
Ireland(4)3.07.94.71.05.7444
Greece(5)5.15.08.06.7793
Cyprus(6)8.523
Hungary2.81.71.60.62.32.65.81.81686
Romania(7)3.21.03.01.21.73.01.9651
Slovakia(8)3.11.03.90.310.08.11.5333
Finland(9)2.72.41.62.02.4183
Sweden(10)1.92.62.31.24.13.3575
United Kingdom2.83.73.30.71.01.02.71.5964
Turkey(11)12.310.05.93.337.513.1935
Total3.74.42.20.72.99.85.42.02.7
Total base3083366107911753125813053077604

Notes:

 (1) No female cases for cocaine and hypnotics; no cases for hallucinogens, volatile substances and other drugs. 

 (2) No female cases for cocaine. 

 (3) No cases for hallucinogens, volatile substances and other drugs. 

 (4) No female cases for hallucinogens; no cases for Volatile substances and other drugs. 

 (5) No female cases for stimulants; no cases for hallucinogens, volatile substances and other drugs. 

 (6) No female cases for cocaine and cannabis; no cases for stimulants, hypnotics, hallucinogens, volatile substances and other drugs. 

 (7) No cases for hallucinogens. 

 (8) No female cases for hallucinogens. 

 (9) No female cases for other drugs; no cases for cocaine and hallucinogens. 

 (10) No female cases for hallucinogens and volatile substances. 

 (11) No female cases for other drugs; no cases for hallucinogens. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - TDI - inpatient treatment centres. 

Page last updated: Monday, 12 November 2007